IGN-402

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIGN-402

Drug Alias Namemulti-epitope anti-cancer vaccines (Igeneon)IGN-401IGN-402

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIgeneon Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIgeneon Ag

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A